Faix JD

Kofoed K

Müller B

Venkatesh B

 There is growing interest in the use of procalcitonin as a biomarker of bacterial infection. In particular, focus has been on the use of procalcitonin to facilitate a more timely diagnosis of sepsis and to guide the appropriate duration of antibiotic therapy. However, there is a lack of consensus in the literature concerning the role of measuring procalcitonin levels in clinical practice. This article reviews the evidence surrounding the utility of this biomarker for patients with sepsis in the intensive care environment. It is concluded that raised procalcitonin levels add little as a diagnostic criterion, however evidence supports the incorporation of procalcitonin-based algorithms relating to antibiotic stewardship in this patient population. </jats:p

Procalcitonin: Does It Have a Role in the Diagnosis, Management and Prognosis of Patients with Sepsis?

Abstract

Similar works

Full text

Available Versions

Crossref